News & Media Coverage
Read the latest lab news and media coverage featuring research from the Youngblood Lab.
- Meningioma Histology and Molecular Testing Workflow Paper Published10.01.2026
Our study led by MSTP candidate Harrsha Congivaram, in collaboration with Dr. Craig Horbinski, has been published in Neuro-Oncology. The work proposes an evidence-based workflow for which meningiomas should get molecular testing.
- Spatial-ATAC-Hi-C Paper Published09.01.2026
In collaboration with the Yue Lab, our new study introducing Spatial-ATAC-Hi-C has been published in Nature Methods. The technology maps 3D genome organization and chromatin accessibility together directly on tissue slides, while keeping the tissue’s spatial layout intact.
- Abhi Mahesh Joins the Lab07.01.2026
Abhi is a recent graduate in Computer Science from the University of Illinois Urbana-Champaign. He will focus on the analysis of high-dimensional datasets and assist with experiments.
- Welcome Summer Medical Students Ella Foster and David Zhang06.15.2026
Ella will focus on understanding STING's role in meningioma cytotoxicity. David is leading a project investigating venous thromboembolism in meningiomas.
- Lara Koutah Joins the Lab05.01.2026
Lara completed her master's degree in the Ahmed Lab last year and will spend a year at the Youngblood Lab leading experimental efforts on multiple projects.
- PitNET Project Receives Funding From Malnati Brain Tumor Institute03.25.2026
The lab has received a new pilot grant from the Lou and Jean Malnati Brain Tumor Institute to investigate molecular drivers of aggressiveness and therapeutic opportunities in pituitary neuroendocrine tumors (PitNETs).
- Meningioma STING Paper Published02.12.2026
Our recent work investigating STING as a therapeutic target in meningiomas has been published in Nature Communications. See additional coverage from Feinberg News.
- Study on Release of Exosomes After Glioblastoma Blood-Brain Barrier Opening Published12.16.2025
Our latest study, published in Nature Communications, shows that glioblastoma patients treated with paclitaxel after blood-brain barrier opening release exosomes in proportion to drug response (overall survival). See news coverage from Northwestern Medicine Newsroom, Feinberg New Center, University of Michigan News, and MedicalXpress.